CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2022			12,843,157
Beginning balance at Dec. 31, 2022	$ 279,929	$ (9,683)	$ 12	$ 4,430,922	$ (4,151,005)	$ (9,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	509			509
Issuance of restricted common stock (in shares)			29,978
Stock options exercised, net (in shares)			461
Repurchases of common stock in open market (in shares)			(375,826)
Repurchases of common stock in open market	(6,327)			(6,327)
Net income	$ 15,887				15,887
Ending balance (in shares) at Dec. 31, 2023	12,497,770		12,497,770
Ending balance at Dec. 31, 2023	$ 280,315		$ 12	4,425,104	(4,144,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	944			944
Forfeiture of unvested restricted stock (in shares)			(6,446)
Issuance of restricted common stock (in shares)			73,364
Stock options exercised, net (in shares)			2,595
Repurchases of common stock in open market (in shares)			(353,684)
Repurchases of common stock in open market	(6,014)			(6,014)
Net settlement for employee taxes on stock options	(43)			(43)
Net income	$ 13,488				13,488
Ending balance (in shares) at Dec. 31, 2024	12,213,599		12,213,599
Ending balance at Dec. 31, 2024	$ 288,690		$ 12	$ 4,419,991	$ (4,131,313)